Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue
Nephrology · 2024
DOI: 10.1111/nep.14365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, 2024. Verfasst von Jonathan Barratt. Beteiligte Einrichtung: University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Immunoglobulin A, Intestinal Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
IgA nephropathy is a mucosally driven disease and new therapeutic approaches are specifically targeting the mucosal production of IgA in the hope that this will lead to a reduction in circulating IgA immune complexes and mesangial IgA deposition. In this lecture, I discuss the rationale for targeting the mucosal immune system of the gut and the existing data from clinical trials supporting such an approach as a disease modifying treatment for IgA nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Leicester, Leicester, UK.
- John Walls Renal Unit, Leicester, UK.
ORCID-Profile: Jonathan Barratt
Zitieren
APA
Barratt, J. (2024). Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue. Nephrology. https://doi.org/10.1111/nep.14365
Vancouver
Barratt J. Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue. Nephrology. 2024. doi:10.1111/nep.14365
BibTeX
@article{Barratt2024,
author = {Barratt, Jonathan},
title = {Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue},
journal = {Nephrology},
year = {2024},
doi = {10.1111/nep.14365}
}
EUVIMED